These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit. Letko E; Gürcan HM; Papaliodis GN; Christen W; Foster CS; Ahmed AR Clin Exp Dermatol; 2007 Nov; 32(6):637-41. PubMed ID: 17524068 [TBL] [Abstract][Full Text] [Related]
30. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen. Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184 [TBL] [Abstract][Full Text] [Related]
31. Anti-laminin-332 mucous membrane pemphigoid associated with recurrent metastatic prostate carcinoma: hypothesis for a paraneoplastic phenomenon. Young AL; Bailey EE; Colaço SM; Engler DE; Grossman ME Eur J Dermatol; 2011; 21(3):401-4. PubMed ID: 21527374 [TBL] [Abstract][Full Text] [Related]
32. Cicatricial pemphigoid with autoantibodies against the laminin 5 gamma 2 subunit. Dainichi T; Takeshita H; Moroi Y; Urabe K; Yoshida M; Hisamatsu Y; Komai A; Duan H; Koga T; Hashimoto T; Furue M Eur J Dermatol; 2005; 15(3):189-93. PubMed ID: 15908306 [TBL] [Abstract][Full Text] [Related]
33. Anti-laminin-332 mucous membrane pemphigoid with autoantibodies to α3, β3 and γ2 subunits of laminin-332 as well as to BP230 and periplakin associated with adenocarcinoma from an unknown primary site. Fukuchi O; Suko A; Matsuzaki H; Baba H; Yoshida H; Takeuchi T; Odawara S; Fukuda S; Hashimoto T J Dermatol; 2013 Jan; 40(1):61-2. PubMed ID: 22901273 [No Abstract] [Full Text] [Related]
34. Subunit-Specific Reactivity of Autoantibodies Against Laminin-332 Reveals Direct Inflammatory Mechanisms on Keratinocytes. Bao L; Li J; Solimani F; Didona D; Patel PM; Li X; Qian H; Ishii N; Hashimoto T; Hertl M; Amber KT Front Immunol; 2021; 12():775412. PubMed ID: 34899732 [TBL] [Abstract][Full Text] [Related]
35. Antiepiligrin cicatricial pemphigoid with autoantibodies to the beta subunit of laminin 5 and associated with severe laryngeal involvement necessitating tracheostomy. Seo SH; Kye YC; Kim SN; Kim SC Dermatology; 2001; 202(1):63-6. PubMed ID: 11244234 [TBL] [Abstract][Full Text] [Related]
36. A case of mucous membrane pemphigoid with IgG antibodies against all the alpha3, beta3 and gamma2 subunits of laminin-332 and BP180 C-terminal domain, associated with pancreatic cancer. Demitsu T; Yoneda K; Iida E; Sasaki K; Umemoto N; Kakurai M; Wakatabi K; Yamada T; Ohyama B; Hashimoto T Clin Exp Dermatol; 2009 Dec; 34(8):e992-4. PubMed ID: 19832858 [No Abstract] [Full Text] [Related]
37. Antiepiligrin (laminin 5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5. Taniuchi K; Takata M; Matsui C; Fushida Y; Uchiyama K; Mori T; Kawara S; Yancey KB; Takehara K Br J Dermatol; 1999 Apr; 140(4):696-700. PubMed ID: 10233324 [TBL] [Abstract][Full Text] [Related]
38. Detachment of keratinocytes at the basement membrane zone caused by inhibitory effect of the antibodies from sera of mucous membrane pemphigoid patients. Koga H; Teye K; Ishii N; Nakama T J Dermatol; 2019 Nov; 46(11):1046-1048. PubMed ID: 31515818 [No Abstract] [Full Text] [Related]
39. Consider antilaminin gamma-1 pemphigoid when faced with conflicting histopathology and immunofluorescence results. Kingsbery MY; Grossman ME; Nguyen H J Am Acad Dermatol; 2013 Feb; 68(2):e60-1. PubMed ID: 23317996 [No Abstract] [Full Text] [Related]
40. Experimental Laminin 332 Mucous Membrane Pemphigoid Critically Involves C5aR1 and Reflects Clinical and Immunopathological Characteristics of the Human Disease. Heppe EN; Tofern S; Schulze FS; Ishiko A; Shimizu A; Sina C; Zillikens D; Köhl J; Goletz S; Schmidt E J Invest Dermatol; 2017 Aug; 137(8):1709-1718. PubMed ID: 28456612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]